help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Autio, P.
Right arrow Articles by Oikarinen, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Autio, P.
Right arrow Articles by Oikarinen, A.

Am. J. Respir. Crit. Care Med., Vol 153, No. 3, Mar 1996, 1172-1175.

Effects of an inhaled steroid (budesonide) on skin collagen synthesis of asthma patients in vivo

P Autio, J Karjalainen, L Risteli, J Risteli, U Kiistala and A Oikarinen
Department of Dermatology, University of Helsinki, Finland.

Skin atrophy has been observed after prolonged use of inhaled corticosteroids. We therefore studied the effect of inhaled budesonide and nedocromil in patients with asthma on concentrations of procollagen propeptides in suction blister fluid reflecting skin collagen synthesis in vivo. Both types I and III procollagen propeptide concentrations decreased significantly after 6 wk of either 1,600 micro g/day (n=10) or 400 micro g/day (n=9) of inhaled budesonide but not in control subjects using inhaled nedocromil 16 mg/day (n=9). The reduction in mean propeptide concentrations ranged from 39 to 63%; the effects of the two budesonide doses did not differ significantly. Thus, even a low dose of inhaled corticosteroid represses skin collagen synthesis within a relatively short period.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
O. Stojadinovic, B. Lee, C. Vouthounis, S. Vukelic, I. Pastar, M. Blumenberg, H. Brem, and M. Tomic-Canic
Novel Genomic Effects of Glucocorticoids in Epidermal Keratinocytes: INHIBITION OF APOPTOSIS, INTERFERON-{gamma} PATHWAY, AND WOUND HEALING ALONG WITH PROMOTION OF TERMINAL DIFFERENTIATION
J. Biol. Chem., February 9, 2007; 282(6): 4021 - 4034.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
N. J. Roland, R. K. Bhalla, and J. Earis
The Local Side Effects of Inhaled Corticosteroids: Current Understanding and Review of the Literature
Chest, July 1, 2004; 126(1): 213 - 219.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
F. T. Leone, J. E. Fish, S. J. Szefler, and S. L. West
Systematic Review of the Evidence Regarding Potential Complications of Inhaled Corticosteroid Use in Asthma: Collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology
Chest, December 1, 2003; 124(6): 2329 - 2340.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
R. Brus
Effects of High-Dose Inhaled Corticosteroids on Plasma Cortisol Concentrations in Healthy Adults
Arch Intern Med, September 13, 1999; 159(16): 1903 - 1908.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. J. BARNES, S. PEDERSEN, and W. W. BUSSE
Efficacy and Safety of Inhaled Corticosteroids . New Developments
Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): S1 - 53.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1996 American Thoracic Society